The Neuroscience of Being Human

The Neuroscience of Poppers

How alkyl nitrites relax smooth muscle through the nitric oxide-cGMP pathway, why a substance sold as room odouriser produces cardiovascular effects within seconds, and what the clinical evidence reveals about methaemoglobinaemia and maculopathy

The Neuroscience of Poppers

1,540-word article with 8 Harvard references.

Key takeaways

  • Alkyl nitrites act by releasing nitric oxide, which activates the enzyme soluble guanylate cyclase, increasing intracellular cyclic guanosine monophosphate and producing rapid relaxation of both vascular and non-vascular smooth muscle. The vasodilation produces the characteristic rush, warmth, and lightheadedness. The relaxation of anal sphincter smooth muscle is the primary reason for the association between poppers and sexual activity (Romanelli et al., 2004).
  • The fundamental mechanism of alkyl nitrites, activation of guanylate cyclase by nitric oxide, was elucidated in work that contributed to the 1998 Nobel Prize in Physiology or Medicine. The same pathway underlies the therapeutic action of nitroglycerin in angina and the mechanism of sildenafil in erectile dysfunction, which is why combining poppers with phosphodiesterase-5 inhibitors produces dangerous, potentially fatal hypotension (Gruetter et al., 1979).
  • Methaemoglobinaemia is a dose-dependent toxicity in which nitrite ions oxidise the iron in haemoglobin from the ferrous to the ferric state, rendering it unable to carry oxygen. At methaemoglobin levels above thirty percent, symptoms include cyanosis, dyspnoea, confusion, and loss of consciousness. At levels above seventy percent, death can occur. Treatment with intravenous methylene blue is effective if administered promptly (Bradberry, 2003).
  • Poppers maculopathy is a recently recognised complication involving damage to the foveal photoreceptors, the cone cells responsible for central vision. Optical coherence tomography reveals disruption of the outer photoreceptor segments in the fovea. The damage can be irreversible, producing permanent impairment of central visual acuity (Davies et al., 2012).
  • A systematic review of the literature found that alkyl nitrite use is associated with elevated risk of ocular damage, cardiovascular events including severe hypotension and reflex tachycardia, methaemoglobinaemia, chemical burns to the skin and airways, and immunological effects whose clinical significance remains under investigation (Rewbury et al., 2017).

The nitric oxide pathway: how poppers work

Alkyl nitrites are simple organic molecules: an alkyl group bonded to a nitrite ester. When inhaled, they are rapidly absorbed through the pulmonary epithelium and enter the systemic circulation within seconds. In the bloodstream, they decompose to release nitric oxide, a gaseous signalling molecule that diffuses freely across cell membranes and activates the enzyme soluble guanylate cyclase in smooth muscle cells. Gruetter et al. (1979), in work that formed part of the foundation for the 1998 Nobel Prize in Physiology or Medicine, demonstrated that nitric oxide activates guanylate cyclase, which converts guanosine triphosphate to cyclic guanosine monophosphate. The increase in cyclic GMP triggers a cascade that reduces intracellular calcium, and reduced calcium means relaxed smooth muscle. Every smooth muscle in the body responds: vascular smooth muscle relaxes, producing vasodilation and a drop in blood pressure; bronchial smooth muscle relaxes; and the smooth muscle of the gastrointestinal and genitourinary tracts relaxes, including the smooth muscle of the anal sphincter.

Romanelli et al. (2004) reviewed the clinical pharmacology and documented the subjective effects: a rapid rush of warmth and lightheadedness as blood pressure drops, facial flushing as cutaneous blood vessels dilate, a brief sense of euphoria lasting thirty to sixty seconds, and increased heart rate as the baroreceptor reflex compensates for the fall in blood pressure. The entire experience is brief because alkyl nitrites are metabolised rapidly, with a plasma half-life measured in minutes. The subjective euphoria is thought to result partly from the transient cerebral vasodilation and partly from the sudden baroreceptor-mediated sympathetic activation. The association with sexual activity, particularly receptive anal intercourse, is pharmacologically direct: the same smooth muscle relaxation that drops blood pressure also relaxes the internal anal sphincter, reducing discomfort during penetration. This functional effect, not recreational euphoria, is the primary driver of poppers use in sexual contexts.

The dangerous interaction with phosphodiesterase-5 inhibitors

The nitric oxide-cGMP pathway that poppers activate is the same pathway that sildenafil, tadalafil, and vardenafil modulate. These phosphodiesterase-5 inhibitors work by preventing the breakdown of cyclic GMP, thereby prolonging and intensifying smooth muscle relaxation. When poppers flood the system with nitric oxide, massively increasing cGMP production, and a PDE5 inhibitor simultaneously prevents the breakdown of that cGMP, the result is profound, sustained vasodilation and a precipitous fall in blood pressure. Romanelli et al. (2004) documented cases of cardiovascular collapse requiring emergency intervention. The interaction is not idiosyncratic. It is a predictable pharmacological consequence of activating two points in the same signalling cascade simultaneously. Every clinical guideline for PDE5 inhibitors includes an absolute contraindication for concurrent nitrite use, yet awareness of this interaction among recreational users of both substances remains inconsistent.

Methaemoglobinaemia: when haemoglobin stops carrying oxygen

Bradberry (2003) provided a comprehensive review of methaemoglobinaemia, the most dangerous acute toxicity of alkyl nitrite inhalation. The mechanism is distinct from the nitric oxide-mediated smooth muscle relaxation. Nitrite ions, absorbed into the bloodstream, directly oxidise the iron atom at the centre of the haemoglobin molecule from the ferrous state to the ferric state. Haemoglobin in the ferric state, called methaemoglobin, cannot bind or transport oxygen. Under normal conditions, methaemoglobin constitutes less than one percent of total haemoglobin. At levels of fifteen to twenty percent, the skin and mucous membranes become visibly cyanotic, turning blue or grey. At levels above thirty percent, patients develop headache, dyspnoea, confusion, and tachycardia. Above fifty percent, seizures, coma, and cardiac arrhythmias develop. Above seventy percent, death is likely without treatment.

The treatment is intravenous methylene blue, which acts as an electron carrier, facilitating the enzymatic reduction of methaemoglobin back to functional haemoglobin. Treatment is effective if administered promptly, but the window for intervention is narrow in severe cases. The risk of clinically significant methaemoglobinaemia increases with repeated inhalation, large doses, prolonged exposure in enclosed spaces, and the use of isopropyl nitrite, which appears to be more potent as a methaemoglobin inducer than amyl or butyl nitrite. Individuals with glucose-6-phosphate dehydrogenase deficiency are at particular risk because they have a reduced capacity to regenerate functional haemoglobin, and methylene blue is ineffective in this population.

Poppers maculopathy: damage to central vision

Davies et al. (2012) published one of the first case series documenting a previously unrecognised complication of poppers use: damage to the foveal photoreceptors causing impaired central vision. Patients presented with reduced visual acuity, central scotomata, and photophobia following poppers use. Optical coherence tomography revealed disruption of the outer photoreceptor layer specifically at the fovea, the region of the retina responsible for sharp central vision. The fovea is populated almost exclusively by cone photoreceptors and has the highest metabolic rate of any tissue in the body. The mechanism by which alkyl nitrites damage these cells is not fully established but may involve nitric oxide-mediated disruption of mitochondrial function in the highly metabolically active foveal cones.

Audo et al. (2011) reported similar findings in a series of habitual poppers users, documenting a characteristic pattern of foveal damage on OCT imaging. In some patients, the damage was reversible with cessation of use. In others, the disruption of the outer photoreceptor segments persisted, leaving permanent impairment of central visual acuity. The condition was most strongly associated with isopropyl nitrite, the compound that has increasingly replaced amyl and butyl nitrite in commercially available products following regulatory changes. The shift from amyl nitrite to isopropyl nitrite appears to have introduced a toxicological risk that the earlier compounds did not carry to the same degree, a pattern seen repeatedly in drug markets where regulatory action changes the available compounds without reducing overall use.

Epidemiology and user populations

Haverkos et al. (1994), reviewing the epidemiology of nitrite inhalant use, documented that poppers use has been concentrated among men who have sex with men since the 1970s, driven primarily by the smooth muscle relaxant effect on the anal sphincter. Use in dance and club settings is also well documented, driven by the brief euphoria and the intensification of music and sensory experience. Rewbury et al. (2017), in a systematic review of the contemporary literature, confirmed that poppers remain one of the most widely used recreational substances in nightlife populations globally. They documented associations with risky sexual behaviour, increased HIV transmission risk through both behavioural mechanisms and potential immunological effects of nitrite inhalation, and a pattern of underreporting in clinical settings due to the brevity of effects and the perception among users that poppers are harmless.

Giorgetti et al. (2017) situated poppers use within the broader context of chemsex, the use of drugs specifically to facilitate or enhance sexual activity. In this context, poppers are frequently combined with other substances including GHB/GBL, methamphetamine, mephedrone, and erectile dysfunction medications. The combination of poppers with PDE5 inhibitors is particularly prevalent in sexual contexts, where both substances serve complementary purposes, yet the pharmacological interaction between them produces the most acutely dangerous consequence of poppers use. The chemsex context also involves patterns of prolonged, repeated inhalation over hours-long sessions, increasing cumulative exposure and the risk of both methaemoglobinaemia and macular damage.

Invitation to reflect

Poppers occupy a peculiar position in the pharmacological landscape. They are one of the most widely used recreational substances, yet they have received remarkably little research attention compared to other drugs. Their mechanism of action, the nitric oxide-cGMP pathway, is one of the most thoroughly studied signalling cascades in all of biology, the subject of a Nobel Prize. Yet the specific toxicological consequences of delivering a bolus of nitric oxide to the bloodstream through volatile nitrite inhalation remain incompletely characterised. The discovery of poppers maculopathy, a condition that was not recognised until 2010, illustrates the gap between the ubiquity of use and the depth of clinical understanding. A substance inhaled by millions of people for decades was causing damage to the foveal photoreceptors that no one had identified. The pharmacology of poppers is straightforward. The clinical toxicology is still being written. And the perception among users that a substance sold legally as room odouriser or leather cleaner must be safe persists, as it always does, in the space between pharmacological reality and regulatory categorisation.

References

  1. Romanelli, F, Smith, KM, Thornton, AC and Pomeroy, C (2004) Poppers: epidemiology and clinical management of inhaled nitrite abuse. Pharmacotherapy, 24(1), pp. 69–78.
  2. Rewbury, R, Hughes, E, Sheringham, J, Piel, FB and Rait, G (2017) Poppers: an overview of the literature on the use and effects of alkyl nitrites. Drug and Alcohol Review, 36(3), pp. 418–432.
  3. Davies, AJ, Kelly, SP and Naylor, SG (2012) Adverse ophthalmic reaction in poppers users: case series of 'poppers maculopathy'. Eye, 26(11), pp. 1479–1486.
  4. Bradberry, SM (2003) Occupational methaemoglobinaemia: mechanisms of production, features, diagnosis and management including the use of methylene blue. Toxicological Reviews, 22(1), pp. 13–27.
  5. Haverkos, HW, Kopstein, AN, Wilson, H and Drotman, P (1994) Nitrite inhalants: history, epidemiology, and possible links to AIDS. Environmental Health Perspectives, 102(10), pp. 858–861.
  6. Gruetter, CA, Barry, BK, McNamara, DB, Gruetter, DY, Kadowitz, PJ and Ignarro, LJ (1979) Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside, and a carcinogenic nitrosoamine. Journal of Cyclic Nucleotide Research, 5(3), pp. 211–224.
  7. Giorgetti, R, Tagliabracci, A, Schifano, F, Zaami, S, Marinelli, E and Busardò, FP (2017) When 'chems' meet sex: a rising phenomenon called 'chemsex'. Current Neuropharmacology, 15(5), pp. 762–770.
  8. Audo, I, El Sanharawi, M, Vignal-Clermont, C, Villa, A, Mohand-Said, S, Grout, O, Couturier, A, Godard, S, Galanaud, D, Paques, M, Sahel, JA and Mauget-Faysse, M (2011) Foveal damage in habitual poppers users. Archives of Ophthalmology, 129(6), pp. 703–708.

About the author

Gareth Strangemore-Jones, MHFA, DCST, PDPCP, HPD, DSFH, DMH, AHD, NCTJ, MSC-CPA, PGCE (FE) I & II

MNCPS (Reg.), MNCH (Reg.), MCNHC (Reg.), MAfSFH (Assoc.)

PSA (Acc.), FSE (Fellow), IFfS (Assoc.)

Mental Health First Aider, Pluralistic Counsellor, Clinical Psychotherapist. Consultant Medical Hypnotherapist, Mindfulness Teacher. PGCE-Trained Teacher, Lecturer, Corporate Trainer, Workplace Wellbeing Consultant. PR & Marketing Consultant, Psychology & Behaviour Advisor. Author, Journalist, Broadcaster. Advocate for Mental Health, People & Planet

Founder, CEO & Clinical Lead, The Brain Gym & Research Ltd. Gold standard human therapy, intelligently delivered